Blood cell palmitoleate-palmitate ratio is an independent prognostic factor for amyotrophic lateral sclerosis

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Henriques, Alexandre ^a,b   Blasco, Hélène ^c,d   Fleury, Marie Céline ^e   Corcia, Philippe ^c,d   Echaniz Laguna, Andoni ^a,b,e   Robelin, Laura ^a,b   Rudolf, Gabrielle ^e   Lequeu, Thiebault ^a,b   Bergaentzle, Martine ^b,f   Gachet, Christian ^b   Pradat, Pierre François ^g   Marchioni, Eric ^b,f   Andres, Christian R ^c,d   Tranchant, Christine ^e   De Aguilar, Jose Luis Gonzalez ^a,b   Loeffler, Jean Philippe ^a,b  

^a Laboratoire des Mecanismes Centraux et Peripheriques de la Neurodegenerescence   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

^e UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^f CNRS   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; FATTY ACID ESTER; LEPTIN; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; MONOUNSATURATED FATTY ACID;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD CELL; BODY MASS; CHEMICAL PARAMETERS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE DURATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; METABOLISM; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PALMITOLEATE PALMITATE RATIO; PREDICTION; PROGNOSIS; SURVIVAL; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; MORTALITY; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BODY MASS INDEX; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; PALMITIC ACID; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 84940045319     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131512     Document Type: Article

References (46)

1. Manjaly ZR, Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, et al. The sex ratio in amyotrophic lateral sclerosis: A population based study. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2010; 11(5):439-42. doi: 10.3109/17482961003610853 PMID: 20225930.
2. Pupillo E, Messina P, Logroscino G, Beghi E, Group S. Long-term survival in amyotrophic lateral sclerosis: a population-based study. Annals of neurology. 2014; 75(2):287-97. doi: 10.1002/ana.24096 PMID: 24382602.
3. Turner MR, Barnwell J, Al-Chalabi A, Eisen A. Young-onset amyotrophic lateral sclerosis: historical and other observations. Brain: a journal of neurology. 2012; 135(Pt 9):2883-91. doi: 10.1093/brain/aws144 PMID: 22661746.
4. de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology. 2008; 119(3):497-503. doi: 10.1016/j.clinph.2007.09.143 PMID: 18164242.
5. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases. 2000; 1(5):293-9. PMID: 11464847.
6. Schmitt F, Hussain G, Dupuis L, Loeffler JP, Henriques A. A plural role for lipids in motor neuron diseases: energy, signaling and structure. Frontiers in cellular neuroscience. 2014; 8:25. doi: 10.3389/fncel.2014.00025 PMID: 24600344; PubMed Central PMCID: PMC3929843.
7. Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. The Lancet Neurology. 2011; 10(1):75-82. doi: 10.1016/S1474-4422(10)70224-6 PMID: 21035400.
8. Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, et al. Hypermetabolism in ALS patients: an early and persistent phenomenon. Journal of neurology. 2009; 256(8):1236-42. doi: 10.1007/s00415-009-5100-z PMID: 19306035.
9. Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neuro-degenerative diseases. 2005; 2(3-4):202-7. doi: 10.1159/000089626 PMID: 16909026.
10. Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. The American journal of clinical nutrition. 2001; 74(3):328-34. PMID: 11522556.
11. Funalot B, Desport JC, Sturtz F, Camu W, Couratier P. High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2009; 10(2):113-7. doi: 10.1080/17482960802295192 PMID: 18792852.
12. Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, Bittar R, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008; 70(13):1004-9. doi: 10.1212/01.wnl.0000285080.70324.27 PMID: 18199832.
13. Dorst J, Kuhnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. Journal of neurology. 2011; 258(4):613-7. doi: 10.1007/s00415-010-5805-z PMID: 21128082.
14. Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve. 2011; 44(1):20-4. doi: 10.1002/mus.22114 PMID: 21607987.
15. Sutedja NA, van der Schouw YT, Fischer K, Sizoo EM, Huisman MH, Veldink JH, et al. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. Journal of neurology, neurosurgery, and psychiatry. 2011; 82(6):638-42. doi: 10.1136/jnnp.2010.236752 PMID: 21471184.
16. Chio A, Calvo A, Ilardi A, Cavallo E, Moglia C, Mutani R, et al. Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology. 2009; 73(20):1681-5. doi: 10.1212/WNL.0b013e3181c1df1e PMID: 19917991.
17. Vinknes KJ, Elshorbagy AK, Nurk E, Drevon CA, Gjesdal CG, Tell GS, et al. Plasma stearoyl-CoA desaturase indices: association with lifestyle, diet, and body composition. Obesity. 2013; 21(3):E294-302. doi: 10.1002/oby.20011 PMID: 23404690.
18. Matthan NR, Ooi EM, Van Horn L, Neuhouser ML, Woodman R, Lichtenstein AH. Plasma phospholipid fatty acid biomarkers of dietary fat quality and endogenous metabolism predict coronary heart disease risk: a nested case-control study within the Women's Health Initiative observational study. Journal of the American Heart Association. 2014; 3(4). doi: 10.1161/JAHA.113.000764 PMID: 25122663.
19. Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013; 79(3):416-38. doi: 10.1016/j.neuron.2013.07.033 PMID: 23931993.
20. van den Boom MA, Wassink MG, Westerman J, de Fouw NJ, Roelofsen B, Op den Kamp JA, et al. In vivo turnover of phospholipids in rabbit erythrocytes. Biochimica et biophysica acta. 1994; 1215(3):314-20. PMID: 7811717.
21. Al-Taan O, Stephenson JA, Spencer L, Pollard C, West AL, Calder PC, et al. Changes in plasma and erythrocyte omega-6 and omega-3 fatty acids in response to intravenous supply of omega-3 fatty acids in patients with hepatic colorectal metastases. Lipids in health and disease. 2013; 12:64. doi: 10.1186/1476-511X-12-64 PMID: 23648075; PubMed Central PMCID: PMC3659039.
22. Wood KE, Lau A, Mantzioris E, Gibson RA, Ramsden CE, Muhlhausler BS. A low omega-6 polyunsaturated fatty acid (n-6 PUFA) diet increases omega-3 (n-3) long chain PUFA status in plasma phospholipids in humans. Prostaglandins, leukotrienes, and essential fatty acids. 2014; 90(4):133-8. doi: 10.1016/j.plefa.2013.12.010 PMID: 24456663.
23. Hussain G, Schmitt F, Loeffler JP, de Aguilar JL. Fatting the brain: a brief of recent research. Front Cell Neurosci. 2013; 7:144. doi: 10.3389/fncel.2013.00144 PMID: 24058332; PubMed Central PMCID: PMC3766822.
24. Hussain G, Schmitt F, Henriques A, Lequeu T, Rene F, Bindler F, et al. Systemic down-regulation of delta-9 desaturase promotes muscle oxidative metabolism and accelerates muscle function recovery following nerve injury. PloS one. 2013; 8(6):e64525. doi: 10.1371/journal.pone.0064525 PMID: 23785402; PubMed Central PMCID: PMC3681796.
25. Yun JM, Surh J. Fatty Acid Composition as a Predictor for the Oxidation Stability of Korean Vegetable Oils with or without Induced Oxidative Stress. Preventive nutrition and food science. 2012; 17(2): 158-65. doi: 10.3746/pnf.2012.17.2.158 PMID: 24471078; PubMed Central PMCID: PMC3866755.
26. de Mello VD, Erkkila AT, Schwab US, Pulkkinen L, Kolehmainen M, Atalay M, et al. The effect of fatty or lean fish intake on inflammatory gene expression in peripheral blood mononuclear cells of patients with coronary heart disease. European journal of nutrition. 2009; 48(8):447-55. doi: 10.1007/s00394-009-0033-y PMID: 19506932.
27. Friesen RW, Innis SM. Dietary arachidonic acid to EPA and DHA balance is increased among Canadian pregnant women with low fish intake. The Journal of nutrition. 2009; 139(12):2344-50. doi: 10.3945/jn.109.112565 PMID: 19864401.
28. Sampath H, Ntambi JM. The role of stearoyl-CoA desaturase in obesity, insulin resistance, and inflammation. Annals of the New York Academy of Sciences. 2011; 1243:47-53. doi: 10.1111/j.1749-6632.2011.06303.x PMID: 22211892.
29. Falcao-Pires I, Castro-Chaves P, Miranda-Silva D, Lourenco AP, Leite-Moreira AF. Physiological, pathological and potential therapeutic roles of adipokines. Drug discovery today. 2012; 17(15-16):880-9. doi: 10.1016/j.drudis.2012.04.007 PMID: 22561894.
30. Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annual review of nutrition. 2007; 27:79-101. doi: 10.1146/annurev.nutr.27.061406.093734 PMID: 17313320; PubMed Central PMCID: PMC2885771.
31. Lindauer E, Dupuis L, Muller HP, Neumann H, Ludolph AC, Kassubek J. Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis. PloS one. 2013; 8(6):e67783. doi: 10.1371/journal.pone.0067783 PMID: 23826340; PubMed Central PMCID: PMC3694869.
32. Gordon PH, Salachas F, Lacomblez L, Le Forestier N, Pradat PF, Bruneteau G, et al. Predicting survival of patients with amyotrophic lateral sclerosis at presentation: a 15-year experience. Neuro-degenerative diseases. 2013; 12(2):81-90. doi: 10.1159/000341316 PMID: 22922503.
33. Jawaid A, Murthy SB, Wilson AM, Qureshi SU, Amro MJ, Wheaton M, et al. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2010; 11(6):542-8. doi: 10.3109/17482968.2010.482592 PMID: 20500116.
34. Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M, et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. Journal of neurology, neurosurgery, and psychiatry. 2011; 82(6):628-34. doi: 10.1136/jnnp.2010.211474 PMID: 21097551.
35. Reich-Slotky R, Andrews J, Cheng B, Buchsbaum R, Levy D, Kaufmann P, et al. Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients. Amyotrophic lateral sclerosis & frontotemporal degeneration. 2013; 14(3):212-6. doi: 10.3109/21678421.2013.770028 PMID: 23452274.
36. Vannice G, Rasmussen H. Position of the academy of nutrition and dietetics: dietary fatty acids for healthy adults. Journal of the Academy of Nutrition and Dietetics. 2014; 114(1):136-53. doi: 10.1016/j.jand.2013.11.001 PMID: 24342605.
37. Arsic A, Vucic V, Tepsic J, Mazic S, Djelic M, Glibetic M. Altered plasma and erythrocyte phospholipid fatty acid profile in elite female water polo and football players. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme. 2012; 37(1):40-7. doi: 10.1139/h11-125 PMID: 22165902.
38. Tepsic J, Vucic V, Arsic A, Blazencic-Mladenovic V, Mazic S, Glibetic M. Plasma and erythrocyte phospholipid fatty acid profile in professional basketball and football players. European journal of applied physiology. 2009; 107(3):359-65. doi: 10.1007/s00421-009-1131-5 PMID: 19633987.
39. Zak A, Vecka M, Tvrzicka E, Hruby M, Novak F, Papezova H, et al. Composition of plasma fatty acids and non-cholesterol sterols in anorexia nervosa. Physiological research / Academia Scientiarum Bohemoslovaca. 2005; 54(4):443-51. PMID: 15588144.
40. Holman RT, Adams CE, Nelson RA, Grater SJ, Jaskiewicz JA, Johnson SB, et al. Patients with anorexia nervosa demonstrate deficiencies of selected essential fatty acids, compensatory changes in nonessential fatty acids and decreased fluidity of plasma lipids. The Journal of nutrition. 1995; 125(4): 901-7. PMID: 7722693.
41. Dube JJ, Amati F, Toledo FG, Stefanovic-Racic M, Rossi A, Coen P, et al. Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide. Diabetologia. 2011; 54(5):1147-56. doi: 10.1007/s00125-011-2065-0 PMID: 21327867; PubMed Central PMCID: PMC3804898.
42. Turyn J, Stojek M, Swierczynski J. Up-regulation of stearoyl-CoA desaturase 1 and elongase 6 genes expression in rat lipogenic tissues by chronic food restriction and chronic food restriction/refeeding. Molecular and cellular biochemistry. 2010; 345(1-2):181-8. doi: 10.1007/s11010-010-0571-x PMID: 20721682.
43. Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101(30): 11159-64. doi: 10.1073/pnas.0402026101 PMID: 15263088; PubMed Central PMCID: PMC503756.
44. Olivan S, Martinez-Beamonte R, Calvo AC, Surra JC, Manzano R, Arnal C, et al. Extra virgin olive oil intake delays the development of amyotrophic lateral sclerosis associated with reduced reticulum stress and autophagy in muscle of SOD1G93A mice. The Journal of nutritional biochemistry. 2014; 25(8):885-92. doi: 10.1016/j.jnutbio.2014.04.005 PMID: 24917047.
45. Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014; 383(9934):2065-72. doi: 10.1016/S0140-6736(14)60222-1 PMID: 24582471.
46. Dorst J, Cypionka J, Ludolph AC. High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: A prospective interventional study. Amyotrophic lateral sclerosis & frontotemporal degeneration. 2013; 14(7-8):533-6. doi: 10.3109/21678421.2013.823999 PMID: 23944684.